No photo of Chethan Ramamurthy

View Scopus Profile

Chethan Ramamurthy

  • 111 Citations
  • 5 h-Index
20132020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chethan Ramamurthy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 111 Citations
  • 5 h-Index
  • 7 Article
  • 4 Review article
  • 1 Comment/debate

Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only

Cajipe, M., Wang, H., Elshabrawy, A., Kaushik, D., Liss, M., Svatek, R., Wu, S., Chowdhury, W. H., Ramamurthy, C. & Mansour, A. M., Apr 2020, In : Urologic Oncology: Seminars and Original Investigations. 38, 4, p. 231-239 9 p.

Research output: Contribution to journal › Article

    • Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer

    Ramamurthy, C., Handorf, E. A., Correa, A. F., Beck, J. R. & Geynisman, D. M., Oct 2019, In : Urologic Oncology: Seminars and Original Investigations. 37, 10, p. 688-695 8 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer

    Anari, F., Ramamurthy, C. & Zibelman, M., Jun 2018, In : Future Oncology. 14, 14, p. 1409-1421 13 p.

    Research output: Contribution to journal › Review article

    • 13 Scopus citations

    Managing adverse effects of immunotherapy

    Gerson, J. N., Ramamurthy, C. & Borghaei, H., May 2018, In : Clinical Advances in Hematology and Oncology. 16, 5, p. 364-374 11 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?

    Ramamurthy, C., Godwin, J. L. & Borghaei, H., Jun 1 2017, In : Current Treatment Options in Oncology. 18, 6, 33.

    Research output: Contribution to journal › Review article

    • 8 Scopus citations

    Press / Media

    Cancer scientists push for diversity in trials; San Antonio center recruiting minorities to make studies better

    Chethan Ramamurthy

    2/2/20 → 2/3/20

    3 items of Media coverage

    Press/Media: Press / Media

    UT Health San Antonio to Hold Precision Medicine in Prostate Cancer Symposium March 2

    Robin J Leach & Chethan Ramamurthy

    2/21/19

    1 item of Media coverage

    Press/Media: Press / Media

    $200K Saved With First-Line Docetaxel for Prostate Cancer

    Chethan Ramamurthy

    6/12/18

    1 item of Media coverage

    Press/Media: Press / Media

    ASCO 2018: First comparison of two prostate cancer therapies finds vastly different cost-effectiveness between strategies

    Chethan Ramamurthy

    6/7/18

    1 item of Media coverage

    Press/Media: Press / Media

    First Comparison of Two Newer Prostate Cancer Therapies Finds Vastly Different Cost-Effectiveness Between Strategies

    Chethan Ramamurthy

    6/2/18

    1 item of Media coverage

    Press/Media: Press / Media